Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa
- PMID: 35134129
- PMCID: PMC8903337
- DOI: 10.1093/cid/ciac077
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa
Abstract
Background: We assessed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding duration and magnitude among persons living with human immunodeficiency virus (HIV, PLHIV).
Methods: From May through December 2020, we conducted a prospective cohort study at 20 hospitals in South Africa. Adults hospitalized with symptomatic coronavirus disease 2019 (COVID-19) were enrolled and followed every 2 days with nasopharyngeal/oropharyngeal (NP/OP) swabs until documentation of cessation of SARS-CoV-2 shedding (2 consecutive negative NP/OP swabs). Real-time reverse transcription-polymerase chain reaction testing for SARS-CoV-2 was performed, and cycle-threshold (Ct) values < 30 were considered a proxy for high SARS-CoV-2 viral load. Factors associated with prolonged shedding were assessed using accelerated time-failure Weibull regression models.
Results: Of 2175 COVID-19 patients screened, 300 were enrolled, and 257 individuals (155 HIV-uninfected and 102 PLHIV) had > 1 swabbing visit (median 5 visits [range 2-21]). Median time to cessation of shedding was 13 days (interquartile range [IQR] 6-25) and did not differ significantly by HIV infection. Among a subset of 94 patients (41 PLHIV and 53 HIV-uninfected) with initial respiratory sample Ct-value < 30, median time of shedding at high SARS-CoV-2 viral load was 8 days (IQR 4-17). This was significantly longer in PLHIV with CD4 count < 200 cells/µL, compared to HIV-uninfected persons (median 27 days [IQR 8-43] vs 7 days [IQR 4-13]; adjusted hazard ratio [aHR] 0.14, 95% confidence interval [CI] .07-.28, P < .001), as well as in unsuppressed-HIV versus HIV-uninfected persons.
Conclusions: Although SARS-CoV-2 shedding duration did not differ significantly by HIV infection, among a subset with high initial SARS-CoV-2 viral loads, immunocompromised PLHIV shed SARS-CoV-2 at high viral loads for longer than HIV-uninfected persons. Better HIV control may potentially decrease transmission time of SARS-CoV-2.
Keywords: COVID-19; HIV; immunocompromised; respiratory virus; shedding duration.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
Similar articles
-
Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014.J Infect Dis. 2018 Sep 8;218(8):1228-1237. doi: 10.1093/infdis/jiy310. J Infect Dis. 2018. PMID: 29800425 Free PMC article.
-
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.medRxiv [Preprint]. 2021 Dec 4:2021.07.20.21260855. doi: 10.1101/2021.07.20.21260855. medRxiv. 2021. Update in: Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X. PMID: 34909794 Free PMC article. Updated. Preprint.
-
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.Chest. 2020 Nov;158(5):1876-1884. doi: 10.1016/j.chest.2020.06.015. Epub 2020 Jun 20. Chest. 2020. PMID: 32569635 Free PMC article.
-
Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.World J Pediatr. 2022 Sep;18(9):582-588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4. World J Pediatr. 2022. PMID: 35665477 Free PMC article. Review.
-
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. doi: 10.1017/ice.2020.1273. Epub 2020 Oct 20. Infect Control Hosp Epidemiol. 2021. PMID: 33077007 Free PMC article. Review.
Cited by
-
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.PLoS Pathog. 2024 Oct 15;20(10):e1012624. doi: 10.1371/journal.ppat.1012624. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39405332 Free PMC article.
-
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection.Nat Commun. 2024 Aug 22;15(1):7240. doi: 10.1038/s41467-024-51539-8. Nat Commun. 2024. PMID: 39174553 Free PMC article.
-
The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection.Viruses. 2024 Jul 21;16(7):1173. doi: 10.3390/v16071173. Viruses. 2024. PMID: 39066335 Free PMC article.
-
How Immunocompromised Hosts Were Left Behind in the Quest to Control the COVID-19 Pandemic.Clin Infect Dis. 2024 Oct 15;79(4):1018-1023. doi: 10.1093/cid/ciae308. Clin Infect Dis. 2024. PMID: 38825885 Free PMC article.
-
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.Open Forum Infect Dis. 2024 Jan 9;11(2):ofae012. doi: 10.1093/ofid/ofae012. eCollection 2024 Feb. Open Forum Infect Dis. 2024. PMID: 38390457 Free PMC article.
References
-
- CDC. COVID-19 interim guidance on duration of isolation and precautions for adults with COVID-19. 2021: 1–9. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed 30 June 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous